Implementation Guide CH VACD
5.0.0 - trial-use
Implementation Guide CH VACD, published by HL7 Switzerland. This guide is not an authorized publication; it is the continuous build for version 5.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7ch/ch-vacd/ and changes regularly. See the Directory of published versions
Generated Narrative: Medication TC-IMMUN-MEDIC-HAVRIX1440
identifier: urn:oid:2.16.756.5.30.1.402.1.3.1.1.1
/359000dc-2cee-4a6e-ab05-577f558840e2
code: HAVRIX 1440 Inj Susp
status: Active
manufacturer: Organization GlaxoSmithKline AG
form: Suspension for injection
amount: 1 milliliter (Details: UCUM codemL = 'mL')/1 Syringe (unit of presentation) (Details: SNOMED CT code733020007 = 'Syringe')
Item[x] |
Immunologic substance (substance) |
LotNumber |
AHAVB946A |